NRCC
NOTICE OF REGISTRATION CONFIRMATION EMAILED
12/30/2025
Back to search
Official data from USPTO
TESSERACT MEDICAL RESEARCH
Did you know this trademark is already registered in United States?
Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.
Active USPTO registrationType: WordOffice: United States
Quick snapshot
TESSERACT MEDICAL RESEARCH
ST13
US500000098944749Class
5
Filing
98944749
Registration
8082977
Risk and opportunity diagnosis
Executive reading for naming, filing, and monitoring decisions.
USPTO status
Active USPTO registration
Case type
Application and registration
Recorded events
16
Latest update
12/31/2025
Trademark type
Word
Nice classes
5
Filing date
01/08/2025
Registration date
12/30/2025
Expiration date
-
Complete case details
Structured fields from the responsible authority and the official record.
Status date
12/30/2025
Last transaction
12/31/2025
Responsible office
United States Patent and Trademark Office
Status code
700
Official register
Principal Register
First use anywhere
07/17/2017
First use in commerce
07/17/2017
Drawing code
4
Owner type
16
Owner location
Laguna Hills, CA
Examiner
WRIGHT,MARCO JABBAR
Law office
N20
Current location
FILE REPOSITORY (FRANCONIA)
Holders and representatives
Holders
Tesseract Medical Research, LLC
Representatives
Tesseract Medical Research, LLC
Technical classification
Nice Classes
Class 5
Vienna Codes
No Vienna codes available.
Goods and services
Class 5
A house mark for dietary supplementsnutritional supplementsnutraceuticals as dietary supplements; medical food supplements
Publications
History of USPTO decisions and trademark events.
16 publications found
R.PR
REGISTERED-PRINCIPAL REGISTER
12/30/2025
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
11/11/2025
PUBO
PUBLISHED FOR OPPOSITION
11/11/2025
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
11/05/2025
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
10/08/2025
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
09/05/2025
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
09/05/2025
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
09/05/2025
GEAN
NOTIFICATION OF EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
06/25/2025
GEAP
EXAMINER'S AMENDMENT/PRIORITY ACTION E-MAILED
06/25/2025
EPEN
COMBINED EXAMINER'S AMENDMENT/PRIORITY ACTION AUTOMATIC ENTRY
06/25/2025
CPEA
EXAMINERS AMENDMENT AND/OR PRIORITY ACTION - COMPLETED
06/25/2025
DOCK
ASSIGNED TO EXAMINER
06/17/2025
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
01/08/2025
NWAP
NEW APPLICATION ENTERED
01/08/2025
Continuous trademark protection
Get notified about every new filing that threatens TESSERACT MEDICAL RESEARCH or your mark.
Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.